Warning: The NCBI web site requires JavaScript to function. more...

PubMed

US National Library of Medicine National Institutes of Health

Create RSS
RSS Settings
- Search: Lukac S[au]
- Number of items displayed:
- Feed name:
Create alert
Advanced
Help

Search results

Items: 13

Select item 302700621.

The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.

Lalić K, Rajković N, Popović L, Lukač SS, Stošić L, Rasulić I, Lalić NM.

Atherosclerosis. 2018 Oct;277:298-303. doi: 10.1016/j.atherosclerosis.2018.08.014.

PMID:: 30270062

Similar articles

Select item 285930262.

Corrigendum to "(-)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats".

Kluknavsky M, Balis P, Puzserova A, Radosinska J, Berenyiova A, Drobna M, Lukac S, Muchova J, Bernatova I.

Oxid Med Cell Longev. 2017;2017:9483845. doi: 10.1155/2017/9483845. Epub 2017 Apr 20.

PMID:: 28593026

Free PMC Article

Similar articles

Select item 278853343.

(-)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats.

Kluknavsky M, Balis P, Puzserova A, Radosinska J, Berenyiova A, Drobna M, Lukac S, Muchova J, Bernatova I.

Oxid Med Cell Longev. 2016;2016:6949020. Epub 2016 Nov 3. Erratum in: Oxid Med Cell Longev. 2017;2017:9483845.

PMID:: 27885334

Free PMC Article

Similar articles

Select item 249526104.

High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors.

Longo DM, Louie B, Ptacek J, Friedland G, Evensen E, Putta S, Atallah M, Spellmeyer D, Wang E, Pos Z, Marincola FM, Schaeffer A, Lukac S, Railkar R, Beals CR, Cesano A, Carayannopoulos LN, Hawtin RE.

J Transl Med. 2014 Jun 21;12:178. doi: 10.1186/1479-5876-12-178.

PMID:: 24952610

Free PMC Article

Similar articles

Select item 210528815.

An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics.

Wang H, Gargano C, Lukac S, Jackson A, Beals C, Smiley P, Drexel M, Ruddy M, Herman G, Johnson-Levonas AO, Medve R, Webster L, Reicin A.

Adv Ther. 2010 Dec;27(12):963-80. doi: 10.1007/s12325-010-0084-8. Epub 2010 Nov 3.

PMID:: 21052881

Similar articles

Select item 174842156.

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, Puchalski D, Giacoletti KE, Sings HL, Lukac S, Alvarez FB, Barr E.

Pediatr Infect Dis J. 2007 Mar;26(3):201-9.

PMID:: 17484215

Similar articles

Select item 170795887.

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.

Block SL, Nolan T, Sattler C, Barr E, Giacoletti KE, Marchant CD, Castellsagué X, Rusche SA, Lukac S, Bryan JT, Cavanaugh PF Jr, Reisinger KS; Protocol 016 Study Group.

Pediatrics. 2006 Nov;118(5):2135-45.